R Motta. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntibodiesAntibody FormationAntibody SpecificityAntineoplastic Agents/therapeutic useBinding SitesComplement System ProteinsHaplorhiniHumansImmunity, Maternally-AcquiredImmunoglobulin GImmunoglobulin MImmunoglobulinsLeukemia/drug therapyLeukemia/therapyLeukemia, Experimental/drug therapyLeukemia, Experimental/therapyMiceNeoplasm TransplantationNeoplasms/drug therapyNeoplasms/therapyProperdinRatsTransplantation ImmunologyTransplantation, Homologous
Substances: See more » AntibodiesAntineoplastic AgentsImmunoglobulin GImmunoglobulin MImmunoglobulinsProperdinComplement System Proteins
Year: 1971 PMID: 5001001 DOI: 10.1016/s0065-230x(08)60520-5
Source DB: PubMed Journal: Adv Cancer Res ISSN: 0065-230X Impact factor: 6.242